BC
TECH icon

Beaconlight Capital’s Bio-Techne TECH Stock Holding History

Beaconlight Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,924
Closed -$3.81M – 46
2020
Q4 		$3.81M Buy
47,924
+27,732
+137% +$2.01M 1.15% 30
2020
Q3 		$1.25M Buy
+20,192
New +$1.31M 0.45% 31

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Beaconlight Capital's TECH Position: Q1 2021 in Review

Beaconlight Capital sold out of Bio-Techne (TECH) in Q1 2021, closing a stake of 47,924 shares — an estimated $3.81M sold.

Beaconlight Capital first reported a position in TECH in Q3 2020 and held it in 2 quarters. The position peaked at $3.81M in Q4 2020. 470 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

  • Beaconlight Capital reported no remaining Bio-Techne position as of Q1 2021 after selling out during the quarter.
  • Beaconlight Capital sold 47,924 Bio-Techne shares in Q1 2021, an estimated $3.81M.
  • Beaconlight Capital first reported a position in Bio-Techne in Q3 2020 and held it in 2 quarters.
  • Beaconlight Capital's Bio-Techne position peaked at $3.81M in Q4 2020.
  • 470 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on Beaconlight Capital's 13F filing for Q1 2021, filed 17 May 2021.